MARZI, ILARIA
MARZI, ILARIA
Scienze Biomediche, Sperimentali e Cliniche 'Mario Serio'
Cell renewing in neuroblastoma: electrophysiological and immunocytochemical characterization of stem cells and derivatives.
2006 BIAGIOTTI T.; D'AMICO M.; MARZI I.; DI GENNARO P.; A. ARCANGELI; WANKE E.; OLIVOTTO M.
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells.
2014 Barbetti V; Morandi A; Tusa I; Digiacomo G; Riverso M; Marzi I; Cipolleschi MG; Bessi S; Giannini A; Di Leo A; Dello Sbarba P; Rovida E.
Chronic myeloid leukemia and hepatoblastoma: Two cancer models to link metabolism to stem cells
2016 Cipolleschi, Maria Grazia; Marzi, Ilaria; Rovida, Elisabetta; Dello Sbarba, Persio
Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets.
2014 Cipolleschi MG; Marzi I; Santini R; Fredducci D; Vinci MC; D'Amico M; Rovida E; Stivarou T; Torre E; Dello Sbarba P; Stecca B; Olivotto M.
Low-dose methotrexate enhances cycling of highly anaplastic cancer cells.
2017 Cipolleschi, Maria Grazia; Marzi, Ilaria; Rovida, Elisabetta; Olivotto, Massimo; Dello Sbarba, Persio
One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a “hypoxic” environment
2014 Rovida E; Marzi I; Cipolleschi MG; Dello Sbarba P
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells
2015 Del Poggetto, E; Tanturli, M; Ben-Califa, N; Gozzini, A; Tusa, I; Cheloni, G; Marzi, I; Cipolleschi, M G; Kashman, Y; Neumann, D; Rovida, E; Dello Sbarba, P
The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents.
2015 Stivarou, T; Cipolleschi, Mg; D'Amico, M; Mannini, A; Mini, E; Rovida, E; Dello Sbarba, P; Olivotto, M; Marzi, I
The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming
2013 I. Marzi; MG. Cipolleschi; M. D'Amico; T. Stivarou; E. Rovida; MC. Vinci; S. Pandolfi; P. Dello Sbarba; B. Stecca; M. Olivotto.
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy.
2014 Rovida E; Peppicelli S; Bono S; Bianchini F; Tusa I; Cheloni G; Marzi I; Cipolleschi MG; Calorini L; Dello Sbarba P
The unveiling of the Warburg effect and the inscribed innovative approach to a radical non toxic anticancer therapy
2018 Crociani, Olivia; Marzi, Ilaria; Cipolleschi, Maria Grazia; Mannini, Antonella; Contini, Massimo; Olivotto, Massimo
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells
2013 V. Barbetti; A. Gozzini; G. Cheloni; I. Marzi; E. Fabiani; V. Santini; P. Dello Sbarba; E. Rovida
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cell renewing in neuroblastoma: electrophysiological and immunocytochemical characterization of stem cells and derivatives. | 2006 | BIAGIOTTI T.; D'AMICO M.; MARZI I.; DI GENNARO P.; A. ARCANGELI; WANKE E.; OLIVOTTO M. | |
| Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. | 2014 | Barbetti V; Morandi A; Tusa I; Digiacomo G; Riverso M; Marzi I; Cipolleschi MG; Bessi S; Giannini A; Di Leo A; Dello Sbarba P; Rovida E. | |
| Chronic myeloid leukemia and hepatoblastoma: Two cancer models to link metabolism to stem cells | 2016 | Cipolleschi, Maria Grazia; Marzi, Ilaria; Rovida, Elisabetta; Dello Sbarba, Persio | |
| Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets. | 2014 | Cipolleschi MG; Marzi I; Santini R; Fredducci D; Vinci MC; D'Amico M; Rovida E; Stivarou T; Torre E; Dello Sbarba P; Stecca B; Olivotto M. | |
| Low-dose methotrexate enhances cycling of highly anaplastic cancer cells. | 2017 | Cipolleschi, Maria Grazia; Marzi, Ilaria; Rovida, Elisabetta; Olivotto, Massimo; Dello Sbarba, Persio | |
| One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a “hypoxic” environment | 2014 | Rovida E; Marzi I; Cipolleschi MG; Dello Sbarba P | |
| Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells | 2015 | Del Poggetto, E; Tanturli, M; Ben-Califa, N; Gozzini, A; Tusa, I; Cheloni, G; Marzi, I; Cipolleschi, M G; Kashman, Y; Neumann, D; Rovida, E; Dello Sbarba, P | |
| The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents. | 2015 | Stivarou, T; Cipolleschi, Mg; D'Amico, M; Mannini, A; Mini, E; Rovida, E; Dello Sbarba, P; Olivotto, M; Marzi, I | |
| The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming | 2013 | I. Marzi; MG. Cipolleschi; M. D'Amico; T. Stivarou; E. Rovida; MC. Vinci; S. Pandolfi; P. Dello Sbarba; B. Stecca; M. Olivotto. | |
| The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. | 2014 | Rovida E; Peppicelli S; Bono S; Bianchini F; Tusa I; Cheloni G; Marzi I; Cipolleschi MG; Calorini L; Dello Sbarba P | |
| The unveiling of the Warburg effect and the inscribed innovative approach to a radical non toxic anticancer therapy | 2018 | Crociani, Olivia; Marzi, Ilaria; Cipolleschi, Maria Grazia; Mannini, Antonella; Contini, Massimo; Olivotto, Massimo | |
| Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells | 2013 | V. Barbetti; A. Gozzini; G. Cheloni; I. Marzi; E. Fabiani; V. Santini; P. Dello Sbarba; E. Rovida |